Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset
- DOI
- 10.1111/apt.70888
- Published
- 2026-07-29
- Container
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/apt.70888,
title = {Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset},
author = {Maria Mironova and Krishna Padmanabhan and David Schneider and Jörn M. Schattenberg and Rohit Loomba},
year = {2026},
journal = {Alimentary Pharmacology \& Therapeutics},
doi = {10.1111/apt.70888},
url = {https://doi.org/10.1111/apt.70888}
}RIS
TY - JOUR TI - Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset AU - Maria Mironova AU - Krishna Padmanabhan AU - David Schneider AU - Jörn M. Schattenberg AU - Rohit Loomba PY - 2026 JO - Alimentary Pharmacology & Therapeutics DO - 10.1111/apt.70888 UR - https://doi.org/10.1111/apt.70888 ER -
APA
Mironova, M., Padmanabhan, K., Schneider, D., Schattenberg, J. M., & Loomba, R. (2026). Clinical Trial: Phase 3 Trial of Resmetirom Versus Placebo in Metabolic Dysfunction‐Associated Steatohepatitis—Reanalysis of Fibrosis Stage 2–3 Subset. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70888
Source records
- crossref · retrieved 2026-09-24T23:34:27.508Z